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Background/aim: The aim of this study was to evaluate the efficiency of in vitro embryo splitting (IES) procedures. We also assessed the
quality of the blastocysts developed from embryos obtained from different sources.
Materials and methods: Good quality embryos at 6–8-cell stages were categorized according to their fertilization sources: 1) frozenwarmed donated embryos, 2) chromosomally abnormal embryos, 3) parthenogenetic embryos, and 4) embryos derived from fertilization
of in vitro matured oocytes (rescue IVM). After IES, splitting and developmental efficiency was assessed. Furthermore, the quality of the
developed blastocysts was evaluated by Hoechst and propidium iodide (PI) staining.
Results: The data showed a high rate of both splitting and developmental efficiency in the frozen-warmed embryos after IES (140%
and 71.7%, respectively), followed by chromosomally abnormal embryos (96.8% and 52.5%, respectively). Results of the Hoechst and
PI staining showed that the mean ± SD cell numbers of the control group were higher (113.11 ± 16.01) than that of twins A (donor
blastomeres embryos, 58 ± 12.2) and B (recipient blastomeres embryos, 50.4 ± 8.5), respectively.
Conclusion: Chromosomally normal embryos enrolled in IES are more potent to develop into viable blastocysts. For research purposes,
1PN and 3PN embryos are the best options for splitting procedures, regardless of the poor quality of developed blastocysts.
Key words: Human embryo, in vitro splitting, blastocyst

1. Introduction
Increasing the number of in vitro embryos can be feasible
using two techniques: somatic cell nuclear transfer (SCNT)
and in vitro embryo splitting (IES). In contrast to cloning
by SCNT, which is a completely artificial procedure, IES
mimics the natural developmental process that occurs
in other embryos created by in vitro fertilization (IVF)
techniques (1). In farm animals, pregnancies have been
reported by IES that led to the live birth of healthy offspring
for sheep (2), horses (3), goats (4), cattle (5), and pigs (6).
Moreover, over two decades, IES or embryo twinning
has been successfully established in veterinary medicine
due to the safe and efficient applications (7). IES efforts
in mammals were first achieved in mouse by investigating
the developmental potential of twin embryos obtained
from cleavage stage embryos at 4- and 8-cell stages (8).
Furthermore, split mouse embryos gave rise to healthy

monozygotic twins comparable in size and morphology to
normal embryos (9). Recently, Tang et al. (10) investigated
the developmental potential of single blastomeres isolated
from 4-cell mouse embryos. They concluded that the
IES could enhance the number of blastocysts; however,
the percentage of high quality blastocysts was the same
compared to that shown by nonsplit embryos (10). For
these approaches, rhesus monkey as a nonhuman primate
seems to be the best model close to humans in terms of
genetics and physiology (11). However, splitting strategies
in rhesus monkeys had limited success in terms of live birth
achievements (12,13). One study obtained 368 identical
twins of rhesus monkeys produced by splitting, which
resulted in four pregnancies and one single live birth from
13 embryo transfers (14). Another study that attempted
blastomere separation for 2- and 4-cell stage embryos of
rhesus monkeys reported a 33% clinical pregnancy rate
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with two twin clinical pregnancies, although no live births
occurred (15).
In 1993, as a preliminary report, IES was carried out
on genetically abnormal (polyploid) human embryos, but
the split embryos arrested shortly after a few cell divisions
(16). After this report, no further studies were published
on human IES until 2008, when scientists obtained a
successful development of split human embryos to the
blastocyst stage by blastomere biopsy (17). They split 4-cell
stage embryos and the four blastomeres obtained were
individually cultured in an empty zona pellucida (ZP).
Later, Illmensee et al. (18) achieved blastocysts developed
from twinned human embryos at the 2- to 5- and 6- to
8-cell stages. To date, very little is known about the quality
of the embryos created in such a way and the findings
are controversial. It was shown that the blastomeres
from late cleavage stage embryos and those derived from
good quality embryos had higher splitting efficiency for
development to the blastocyst stage (18). On the other
hand, a recent study suggested that twin human embryos
created by splitting techniques were suitable neither for
clinical nor for research purposes (19). It was shown that
twin blastocysts from IES were significantly smaller than
the control group (17). However, since embryo splitting
is a potential method to improve the efficacy of assisted
reproductive technology (ART) treatments, this technique
was approved by the American Society for Reproductive
Medicine’s ethics committee (20).
Regarding the scarcity of human embryos with
acceptable quality for research, the application of embryo
splitting technology may be a method useful to increase
the number of available human embryos. Hence, immature
oocytes as well as chromosomally abnormal embryos can
be a good source of embryos available for IES application.
The aim of the present study was to evaluate the applicable
potential of a developed technology, i.e. human IES,
regarding its efficacy at different early embryonic stages
(splitting efficacy) and success rates of twin embryo
development to the blastocyst stage (developmental
efficacy). The quality of twinned blastocysts was also
assessed regarding cell count and viability.
2. Materials and methods
2.1. Samples
The present study was approved by the ethics committee
of the Research and Clinical Center for Infertility,
Yazd Reproductive Sciences Institute, Shahid Sadoughi
University of Medical Sciences, Yazd, Iran (Reference
Number:
IR.SSU.MEDICIN.REC.1395.93).
Signed
forms of consent were obtained from all couples for
using discarded oocytes and embryos, and also donated
frozen-warmed embryos in our study. Discarded oocytes
and embryos consisted of the germinal vesicle (GV) and

metaphase I (MI) stage oocytes, and chromosomally
abnormal embryos including aneuploid (1PN and 3PN)
and parthenogenetic embryos obtained from IVF/ICSI
cycles that are usually discarded during ART. The mean ±
SD of the patients’ ages in each group was 34.1 ± 4.27 years
for frozen-warmed embryos, 33.16 ± 4.22 for aneuploidy
embryos, 33.32 ± 4.6 for parthenogenetic embryos, and
32.33 ± 3.6 for embryos created from in vitro matured
oocytes.
2.2. IVM, ICSI, and in vitro culture
Retrieved cumulus–oocyte complexes (COCs) were
denuded of their cumulus and corona cells using
mechanical and enzymatic treatment (80 IU ml–1
hyaluronidase, Irvine Scientific, Irvine, CA, USA) as
described previously (21). The denuded oocytes were
classified as either mature (MII) or immature (GV or MI)
oocytes. Good quality immature oocytes were cultured in
blastocyst medium (G-2 v5 Media, Vitrolife, Sweden) (22)
supplemented with 75 mIU mL–1 FSH and 75 mIU mL–1
LH (Ferring) at 37 °C in an incubator under 5% CO2 and
95% air with high humidity. The maturity of the oocytes
was assessed using a stereomicroscope (Olympus, Tokyo,
Japan) 24 h after IVM. The matured oocytes were injected
with spermatozoa. Fertilization was assessed 16–22 h after
microinjection and the resulting zygotes were cultured in
droplets of 20 µL of G-1 v5 Media (Vitrolife, Sweden) until
the 8-cell stage.
Regarding the discarded embryos, on fertilization
assessment day, the 1PN and 3PN zygotes and unfertilized
oocytes were picked out from normally fertilized oocytes
and were cultured in droplets of 20 µL of G-1™ v5 media
(Vitrolife, Sweden), separately. Finally, grades A and B
8-cell cleaved embryos were selected for in vitro splitting.
2.3. Warming procedure
Donated embryos used in the study were cryopreserved
using the vitrification method. The embryos were warmed
using the RapidWarm Cleave kit (Vitrolife, Sweden)
according to the manufacturer’s instructions. Before they
were manipulated, the embryos were cultured for at least
4 h in microdrops of 20 µL of G-1 v5 Media (Vitrolife,
Sweden) in a humidified atmosphere at 37 °C, in 6% CO2
and 5% O2.
2.4. Embryo micromanipulation
Prior to biopsy to facilitate separation of blastomeres,
the embryos were preincubated in microdrops of Ca+2Mg+2-free culture medium (PGD medium, Vitrolife,
Sweden) overlaid with mineral oil for 10 min at 37 °C.
A hole of 35–40 µm was made in the ZP using a 1480nm wavelength infrared diode laser (OCTAX Laser Shot;
MTG, Germany). Arrested embryos or discarded oocytes
were evacuated with the same technique to obtain empty
ZPs for blastomere recipients. Half of the blastomeres were
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biopsied by aspiration using a micropipette with inner
diameter of 35 µm and inserted one by one into a previously
prepared empty ZP (Figure 1). After splitting, donor
blastomere embryos (twins A) and recipient blastomere
embryos (twins B) were carefully washed and cultured on
G-2 v5 Media (Vitrolife, Sweden) covered with mineral oil

in 6% CO2 at 37 °C. Development of the twin embryos was
followed using an inverted microscope (TE300; Nikon,
Tokyo, Japan) every 24 h up to the blastocyst stage.
2.5. Blastocyst viability
For determining the cell number and cell viability, the
developed in vitro twin blastocysts were assessed in

Figure 1. Human embryo twinning procedure. A) A triploid human embryo at cleavage stage with 8 blastomeres was used as the
blastomere donor embryo (twin A). B) Half of the blastomeres were biopsied through the created hole in the ZP. C) An empty ZP by
source of the discarded oocytes. D) The biopsied blastomeres were inserted into the empty ZP, one by one, as the blastomere recipient
embryo (twin B) E) At the end of the procedure, twinned 4-cell embryos were cultured in vitro to the blastocyst stage (magnification
20×).
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response to propidium iodide (PI) and bisbenzimide
(H33342) fluorochromes, as described earlier (23).
Expanded blastocysts were first washed three times in
prewarmed Ca+2- and Mg+2-free phosphate buffer saline
(PBS-) and then incubated in freshly prepared preincubated
staining solutions of Hoechst (H33342, Cat. No. H33342,
5 µg/mL) and PI (Cat. No. P 4127, 300 µg/mL) for 30 and
10 min, respectively, in a humidified atmosphere at 37 °C
in 6% CO2 and 5% O2. Blastocysts were then washed three
times with warm PBS- to remove the residual dyes and
mounted in a drop of glycerol between two lines of paraffin
wax. A coverslip was placed on top of the embryos and
gently pressed until the embryos were slightly flattened.
Prepared samples were examined under a fluorescent
inverted microscope (Olympus BX51) at 100× and 400×
magnifications using the same excitation wavelength
(330–385 nm) and barrier filter (400 nm) to visualize both
dyes. H33342 has potency to enter all cells, viable or dead,
whereas only cells with altered membrane integrity are
permeable to PI. Therefore, the nuclei of viable cells will
appear blue, while the dead cells are seen as red.
2.6. Statistical analysis
Statistical analysis was performed using SPSS (SPSS Inc.,
Chicago, IL, USA). One-way ANOVA tests, independent
samples t-tests, and Mann–Whitney U tests were applied
whenever appropriate for comparison of quantitative data
between groups. P ˂ 0.05 was considered as statistically
significant.
3. Results
Embryo twinning was carried out on four categories of
human embryos regarding their source, including frozenwarmed donated embryos (n = 20), chromosomally
abnormal embryos (n = 32), parthenogenetic embryos (n
= 22), and embryos derived from fertilization of in vitro
matured oocytes (rescue in vitro maturation (IVM) (n =
18). All of the embryos were at 6–8-cell stage and classified
as good quality embryos. The splitting and developmental
efficiency of these embryos were evaluated and compared
among the four groups. The total mean ± SD of the patients’
ages was 33.24 ± 4.19 years. Moreover, the women’s ages
were not different between groups (P = 0.64). The embryos
were generated from IVF (n = 29) and ICSI (n = 56) cycles.
Embryos created from testicular sperm samples, donation,
and assisted fertilization cycles were excluded from the
study.
The data showed a higher rate of both splitting
and developmental efficiency in the frozen-warmed
embryos (140% and 71.7%, respectively; Table), followed
by chromosomally abnormal embryos (96.8% and
52.5%, respectively). The embryos developed after IVM
procedures had lower rates of splitting and developmental
efficiency (16.6% and 10.7%, respectively; Table). From

28 embryos in this group, only one blastocyst was formed
after IES.
The blastocysts developed from frozen-warmed
donated embryos and 3PN zygotes were used for quality
evaluation by Hoechst and PI staining. In respect of the
total cell number of the blastocysts, our data suggested a
significant difference between the split embryo blastocysts
(twins A and B) and the blastocysts in the control group
(Figures 2 and 3).The mean ± SD cell number of the control
group was higher (113.11 ± 16.01) than that of twins A
(58 ± 12.2) and B (50.4 ± 8.5) (P ˂ 0.0001). Moreover, the
average total number of cells in twins A was insignificantly
higher compared to twins B. In subanalysis, it was shown
that the number of dead cells differed significantly between
the group of twins A and B and the control group, being
lower in the split embryo blastocysts (9.38 ± 3.8 in twins
A vs. 14.67 ± 4.5 in controls, P ˂ 0.0001; and 11.38 ± 3.1
in twins B vs. 14.67 ± 4.5 in controls, P = 0.04; Figure 4).
Furthermore, there was a trend in increasing number
of dead cells in twins B compared to twins A, but the
differences were not significant (P = 0.27; Figure 4).
4. Discussion
This study documented that IES can be a possible method
for increasing the number of viable embryos for any
purpose. According to earlier studies, the optimum result
would be achieved when high quality embryos at 6- to
8-cell stage are selected for in vitro splitting (18). Despite
using high quality embryos for splitting in four groups, our
findings showed that embryos with normal fertilization
conditions had the best splitting and developmental
efficiency compared with abnormal fertilization embryos
and embryos following IVM programs (Table).
In clinical approaches, the numerical increasing
of embryos is beneficial for patients enrolled in IVF
programs, especially for women at advanced ages and
patients considered as “poor responders” (20,24,25). A very
limited number of studies have been conducted on in vitro
splitting in humans and also in chromosomally normal
embryos. The published data, especially from studies on
human embryos, are controversial. Several recent studies
have suggested that the embryo splitting technique
can be a potential method for production of viable and
morphologically adequate blastocysts (17,18,24). However,
they did not present qualitative assessments of blastocysts
created using in vitro splitting. The most recent study by
Noli et al. reported that the embryo splitting method by
blastomere biopsy was not suitable for clinical aims (19).
Our study on donated frozen-warmed embryos with
normal fertilization state showed a high splitting efficiency
(140%; Table).
To the best of our knowledge, this is the first study using
Hoechst and PI staining for cell numbering and quality
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Table. Comparison of splitting and developmental efficiency* after IES according to the sources of embryos.
Source type of
embryos

Embryo development
Embryos
Embryos
manipulated survived after
Splitting efficiency, % (n/N) Developmental efficiency, % (n/N)
Morula Blastocyst
for twinning twinning

Frozen-warmed
Aneuploid
Parthenogenetic
IVM-derived

20
32
22
18

39
59
40
28

10
13
6
2

18
18
2
1

140 (28/20)
96.8 (31/32)
36.3(8/22)
16.6 (3/18)

71.7 (28/39)
52.5 (31/59)
20 (8/40)
10.7 (3/28)

*Splitting efficiency was defined as the ratio of morula and blastocysts to embryos manipulated for twinning. Developmental efficiency
was defined as the ratio of morula and blastocysts to the embryos available after twinning.

Figure 2. Hoechst and PI staining of the blastocysts as a valuable approach for assessment of the number of viable and
dead cells. The figure shows three blastocysts developed from different sources: A) from twin A embryo after in vitro
twinning; B) from twin B embryo after in vitro twinning; C) from embryo without any manipulation. The nuclei of viable
cells appear blue, while dead cells are seen as red.

assessment of twin blastocysts. Some studies showed a
significant difference in size in blastocysts following in
vitro embryo splitting regardless of whether they were
twins A or B (19), but failed to note the exact total number
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of derived blastocyst cells. In respect to cell counting,
we used the blastocysts developed from frozen-warmed
donated embryos and 3PN zygotes. Blastocysts developed
from other sources were not stained due to their poor
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Figure 3. Total cell number of blastocysts compared between groups. There were
significant differences between twins A and twins B with control groups (*P ˂
0.0001). Data are presented as mean ± SD.

Figure 4. The number of dead cells compared between groups. There were significant differences between twins A and control group
and also twins B and control group (*P ˂ 0.0001, **P = 0.04). Data are presented as mean ± SD.
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quality. In this regard, the data showed a lower number
of cells in twin blastocysts compared to the control ones
(Figure 3). This result seems consistent with the fact that
the number of blastomeres in twin embryos was reduced
in comparison with that of intact embryos. Also, there
was a lower number of cells in twins B than in twins A.
This result may be due to technical errors. In some in vitro
twinning cycles, one blastomere was degenerated during
blastomere insertion into the empty ZP, so the number of
blastomeres that participated in the blastocyst formation
was reduced in recipient embryos. Moreover, the number
of dead cells was higher in the control group compared
to the other two groups (Figure 4). Our hypothesis is that
dead cell number is in positive relation with the total cell
number.
Past studies reported that triploidy can be observed
in term-born infants, although survival was limited to a
few days (26). It can be concluded from these findings that
triploid embryos can be developed to blastocyst stage, even
implanted in the endometrium. These chromosomally
abnormal embryos discarded after fertilization assessment
can thus be a good source of human embryos for surveys
of the IES technique. Preliminary studies on human
embryo splitting were done using triploid embryos (16,17).
Illmensee et al. showed that the micromanipulation of
triploid embryos finalized with in vitro splitting did not
influence the developmental efficiency of split embryos
compared to nonsplit control embryos (17).
Rescue IVM is a procedure in association with immature
oocytes that are retrieved from controlled ovarian
hyperstimulation (COH) cycles. Generally, in the routine
policy of many IVF settings, these immature oocytes from
COH cycles are discarded. However, the study by Veeck et
al. (27) showed that these immature oocytes were capable
of not only reaching maturation and fertilization in vitro,
but also of embryonic development. We thus carried out
ICSI following an IVM procedure for immature oocytes
and in vitro splitting for deriving good quality embryos

subsequently. Nevertheless, our data resulted in the lowest
splitting and developmental efficiency for IVM-derived
embryos compared to the other embryos (Table). Embryo
splitting can have possible benefits in human reproductive
research. Due to the scarcity of donated human embryos
for research purposes, the splitting technique would
be helpful for increasing the number of available viable
embryos. In addition, with the preference for blastocyst
transfer in ART cycles, there has been a reduction of
cleavage stage embryos for research (1). Moreover, embryo
splitting provides genetically identical embryos that are
a good option for case-control studies. The use of these
embryos for comparative research eliminates the probable
bias due to the same genetic background. Another usage
of embryo splitting is including it in quality control assays,
training students and embryologists, and establishing
new technologies (19). The main goal of the present study
was the evaluation of the splitting efficiency in discarded
embryos for these mentioned applications.
As previously anticipated, a recent report on IES
suggested that this new method was suitable neither for
clinical use nor for research (19). However, according to
the very low rate of 2.3% multiple pregnancies following
single embryo transfer cycles compared to the rates of
0.4%–0.45% in natural conception, it seems that IES
will find clinical use in reproductive medical science.
Regarding the increasing number of embryos created
using IES, this procedure can be used for poor responders
with low numbers of oocytes or embryos. Accordingly,
the assessment of the developmental potential of embryos
using IES in poor responders is suggested in future studies.
In conclusion, chromosomally normal embryos enrolled
in IES are able to develop up to the viable blastocyst
stage. Regarding research approaches, abnormal fertilized
oocytes (1PN and 3PN) are among the best options for
splitting procedures, regardless of the poor quality of
developed blastocysts.
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